Acquisitions

In January 2021, Ashfield completed the acquisition of PHMR Limited (“PHMR”), a market access consultancy employing over 40 people in the UK and Ireland.

We acquired Canale Communications, an award-winning San Diego-based strategic communications agency.

Visit website

We acquired Incisive Health, a UK-based healthcare communications consultancy, which specialises in healthcare policy, public affairs and communication services.

Visit website

We acquired Putnam Associates, a US-based specialist consultancy focused on product commercialisation strategy, exclusively for the life sciences industry.

Visit website

We acquired Create NYC, a New York-based disruptive creative communications agency offering the tactical execution of sales and marketing materials for its international pharmaceutical clients.

Visit website

The acquisition of SmartAnalyst, a New York-based strategic commercialisation consulting and analytics business, focused on the pharmaceutical and biotech sector.

Visit website

We acquired Sellxpert, a German and Swiss contract sales outsourcing business, based in Speyer, Germany and Basel, Switzerland, cementing our footprint in the DACH region.

The acquisition of Vynamic, a US-based healthcare industry management consultancy, further strengthened and expanded our Advisory offering.

Visit website

We acquired Cambridge Biomarketing, a full-service advertising and communications agency focused on orphan diseases and specialty markets.

Visit website

Our final acquisition of 2017 was the acquisition of MicroMass Communications, a US-based healthcare communications agency specialising in behavioural change.

Visit website

The acquisition of STEM Marketing was our first move into the Advisory space. STEM is the leading global provider of commercial, marketing and medical audits to pharmaceutical companies.

Visit website

In 2016, we acquired Pegasus, one of the most successful integrated healthcare communications consultancies in the UK.

Visit website

We formalised our joint venture with CMIC in 2015, creating CMIC Ashfield, a contract sales solution in Japan.

Visit website

The acquisition of Galliard and Nyxeon in 2014, diversified our healthcare communications portfolio to include scientific PR.

KnowledgePoint360 is our largest acquisition to date, making Ashfield a global market leader in healthcare communications.

This Spanish CSO deepened Ashfield’s commercial presence in Europe.

The acquisition of Medical Communications Group (MCG), a Canadian-based commercial services provider strengthened our offering in Canada.

Through the acquisition of Pharmexx, we added true international reach and depth to our contract sales capabilities through our expansion into 8 new countries.

Visit website

The acquisition of Bilcare in the US and the UK added clinical trial and supply chain packaging expertise to our packaging portfolio.

Visit website

WaterMeadow Medical was acquired in 2012.

Drug Safety Alliance was acquired in 2012.

Synopia RX was acquired in 2012.